 |
|
|
| |
The English hepatitis C registry shows only a modest effect from non- completion of directly-acting antivirals for hepatitis C: SVR rates over 80% in genotype 1, 2 or 3 HCV if more than one third of planned treatment is complete
|
| |
| |
EASL Adherence & DAAs: how much is necessary to Achieve SVR: 75% in 1 study Achieves SVR & 50% in 2nd Study Achieves >90% SVR rate - (09/04/20)
EASL 2020 Aug 27-29 virtual
Reported by Jules Levin
K. Drysdale1, Y. Ntuli1, J. Bestwick2, C. Townley3, F. Mahomed4 and G.R. Foster1
1. Barts Liver Centre, Blizard Institute, Queen Mary University of London, London, UK.
2. Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, UK
3. Specialised Services National Support team, NHS England, Southampton, UK.
4. NHS Arden and Greater East Midlands Commissioning Support Unit, Leicester, UK.
|
| |
|
|
|
|
|
